About the journal
Oncology in Clinical Practice is an open-access journal published by Via Medica in Poland, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Via Medica
- ISSN
- 2450-1654 · 2450-6478
- Country
- Poland
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 186
- Declared review time
- 13 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.viamedica.pl/oncology_in_clinical_practice
Index listings
- DOAJ · 2025-09-22
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 13 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
186
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
904
Last recorded publication year
2025
h-index
13
i10-index
18
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2025-09-22
- Added to DOAJ
- 2025-09-22
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- Portico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Continues
- 1734-6460
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
Show all subjects (50)
- Neuroendocrine Tumor Research Advances
- Lung Cancer Research Studies
- Neuroendocrine Tumor Research Advances
- Lung Cancer Research Studies
- Multiple and Secondary Primary Cancers
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Multiple and Secondary Primary Cancers
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Sarcoma Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Sarcoma Diagnosis and Treatment
- Melanoma and MAPK Pathways
- Lung Cancer Diagnosis and Treatment
- Melanoma and MAPK Pathways
- Lung Cancer Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- Cutaneous Melanoma Detection and Management
- Cutaneous Melanoma Detection and Management
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Lymphoma Diagnosis and Treatment
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Lymphoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Advanced Breast Cancer Therapies
- Gastric Cancer Management and Outcomes
- Advanced Breast Cancer Therapies
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
Keywords (DOAJ)
- oncology
- cancer
- neoplastic
- chemotherapy
- radiotherapy
- radiation oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ